You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

agomelatine

Showing 1 - 25 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in

Not yet recruiting
  • Polymorphism, Genetic
  • +5 more
    • (no location specified)
    Nov 3, 2023

    Depression, Acute Ischemic Stroke Trial (Agomelatine, Placebo Tablets)

    Not yet recruiting
    • Depression
    • Acute Ischemic Stroke
    • Agomelatine
    • Placebo Tablets
    • (no location specified)
    Jul 26, 2022

    Schizophrenia, Negative Symptoms in Schizophrenia Trial in Shanghai (Agomelatine)

    Recruiting
    • Schizophrenia
    • Negative Symptoms in Schizophrenia
    • Agomelatine
    • Shanghai, China
      Shanghai Mental Health Center
    Dec 9, 2022

    15 Different Antidepressants in Major Depressive Disorder

    Completed
    • Major Depressive Disorder
    • Copenhagen, Denmark
      Psychiatric Center Copenhagen
    Jul 18, 2023

    MDD Trial in Changsha (Agomelatine, Placebos)

    Unknown status
    • MDD
    • Agomelatine
    • Placebos
    • Changsha, Hunan, China
      Mental Health Institute & Faculty of Psychiatry of The Second Xi
    Oct 9, 2020

    Hepatic Impairment Trial in Orlando (AGO178)

    Completed
    • Hepatic Impairment
    • Orlando, Florida
      Orlando Clinical Research Center
    May 6, 2021

    MDD Trial in Puerto Rico, United States (Agomelatine, paroxetine, )

    Completed
    • Major Depressive Disorder
    • Agomelatine
    • +2 more
    • Phoenix, Arizona
    • +46 more
    Dec 15, 2020

    MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

    Completed
    • Major Depressive Disorder
    • Agomelatine (AGO178C)
    • Placebo
    • Birmingham, Alabama
    • +47 more
    Dec 15, 2020

    MDD Trial in Puerto Rico, United States (agomelatine, )

    Completed
    • Major Depressive Disorder
    • agomelatine
    • placebo
    • Scottsdale, Arizona
    • +43 more
    Dec 15, 2020

    MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

    Completed
    • Major Depressive Disorder
    • Agomelatine (AGO178C)
    • Placebo
    • Birmingham, Alabama
    • +44 more
    Dec 16, 2020

    Obsessive Compulsive Disorder Trial in Tel Hashomer (Agomelatine A, Placebo)

    Completed
    • Obsessive Compulsive Disorder
    • Agomelatine A
    • Placebo
    • Tel Hashomer, Israel
      Department of Psychiatry Chaim Sheba Medical Center
    Jan 2, 2020

    MDD (MDD) Trial in United States (agomelatine, )

    Completed
    • Major Depressive Disorder (MDD)
    • agomelatine
    • placebo
    • Mesa, Arizona
    • +50 more
    Dec 15, 2020

    MDD Trial in Kaohsiung (electroconvulsive therapy, agomelatine, Placebo)

    Completed
    • Major Depressive Disorder
    • electroconvulsive therapy
    • +2 more
    • Kaohsiung, Taiwan
      Kaohsiung Municipal Kai-Syuan Psychiatric Hospital
    Nov 27, 2019

    MDD Trial in United States (agomelatine, )

    Completed
    • Major Depressive Disorder
    • agomelatine
    • placebo
    • Birmingham, Alabama
    • +77 more
    Dec 15, 2020

    Depression After SARS-CoV-2 (TELESPHOR)

    Recruiting
    • Depression
    • COVID-19
      • Moscow, Russian Federation
        Federal State Autonomous Educational Institution of Higher Educa
      Oct 25, 2022

      Parkinson Disease, Depression, Sleep Disorders Trial (Agomelatine or PIacebo)

      Unknown status
      • Parkinson Disease
      • +3 more
      • Agomelatine or PIacebo
      • (no location specified)
      Jun 5, 2019

      MDD Trial in Puerto Rico, United States (AGO178)

      Terminated
      • Major Depressive Disorder
      • Birmingham, Alabama
      • +97 more
      Dec 16, 2020

      Depressive Disorder, Treatment-Resistant Trial (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

      Withdrawn
      • Depressive Disorder, Treatment-Resistant
      • Esketamine 28 mg
      • +10 more
      • (no location specified)
      Nov 22, 2019

      Prediction of Adolescents With MDD Response to ECT Via MRI

      Recruiting
      • Major Depressive Disorder
      • +2 more
      • Modified Electroconvulsive Therapy
      • Conventional pharmacotherapy
      • Chongqing, Province, China
        The First Affiliated Hospital of Chongqing Medical University
      May 26, 2023

      Depression in Old Age Trial in Saint-Avé, Rennes (Wheelchair)

      Recruiting
      • Depression in Old Age
      • Wheelchair
      • Saint-Avé, Bretagne, France
      • +1 more
      Aug 5, 2022

      Melatonin Decreases Eye Pressure in Normotensive Patients

      Completed
      • Depressive Disorder
      • Agomelatine 25 MG Oral Tablet
      • Kahramanmaraş, Turkey
        Kahramanmaras Sutcuimam University Ophthalmology Department
      Aug 10, 2018

      Generalized Epilepsy Trial in Bhubaneswar (Melatonin 3 mg, Placebo)

      Completed
      • Generalized Epilepsy
      • Melatonin 3 mg
      • Placebo
      • Bhubaneswar, Odisha, India
        All India Institute of Medical Sciences (AIIMS)
      Sep 1, 2020

      Postoperative Pain, Delirium, Confusion Trial in New York (Melatonin, Placebo)

      Completed
      Has Results
      • Postoperative Pain
      • +3 more
      • New York, New York
        Hospital for Special Surgery
      Apr 19, 2022

      Schizophrenia, Schizoaffective Disorder, Delusional Disorder Trial in Mannheim (agomelatine)

      Completed
      • Schizophrenia
      • +2 more
      • agomelatine
      • Mannheim, Baden-Württemberg, Germany
        Central Institute of Mental Health
      Mar 7, 2018

      Dementia, Depression, Schizophrenia Trial in Germany (Phenobarbital, Phenytoin, Carbamazepine)

      Terminated
      • Dementia
      • +4 more
      • Augsburg, Germany
      • +4 more
      Feb 27, 2018